Home > Insider Trading > Filing (0001012975-11-000216)

Filing Details

Accession Number:: 0001012975-11-000216
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-07-20 17:53:26
Reporting Period:: 2011-07-18

Filing Date:: 2011-07-20
Accepted Time:: 2011-07-20 17:53:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1178711	Transcept Pharmaceuticals Inc	TSPT	Pharmaceutical Preparations (2834)	330960223

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1192212	O. Philippe Chambon	C/O New Leaf Ventures Times Square Tower, 7 Times Sq, Ste 3502 New York NY 10036	No	No	No	Yes
1231092	James Niedel	C/O New Leaf Ventures Times Square Tower, 7 Times Sq, Ste 3502 New York NY 10036	No	No	No	Yes
1247851	Ronald Hunt	C/O New Leaf Ventures Times Square Tower, 7 Times Sq, Ste 3502 New York NY 10036	No	No	No	Yes
1253170	Srinivas Akkaraju	C/O New Leaf Ventures 2500 Sand Hill Road, Suite 203 Menlo Park CA 94025	No	No	No	Yes
1340806	K Vijay Lathi	C/O New Leaf Ventures 2500 Sand Hill Road, Suite 203 Menlo Park CA 94025	No	No	No	Yes
1375661	New Leaf Ventures I, L.p.	C/O New Leaf Ventures Times Square Tower, 7 Times Sq, Ste 3502 New York NY 10036	No	No	No	Yes
1441563	Jeani Delagardelle	C/O New Leaf Ventures 2500 Sand Hill Road, Suite 203 Menlo Park CA 94025	No	No	No	Yes
1455597	New Leaf Venture Management I, L.l.c.	C/O New Leaf Ventures Times Square Tower, 7 Times Sq, Ste 3502 New York NY 10036	No	No	No	Yes
1455617	New Leaf Venture Management I, L.p.	C/O New Leaf Ventures Times Square Tower, 7 Times Sq, Ste 3502 New York NY 10036	No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-07-18	162,527	$4.49	1,264,502	No	4	S	Direct
Common Stock	Disposition	2011-07-19	82,535	$4.45	1,181,967	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $4.515 to $4.43 per share. The reporting persons undertake to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The securities are directly held by New Leaf Ventures I, L.P. ("NLV I") and indirectly held by New Leaf Venture Management I, L.P. ("NLV Venture Management"), the sole general partner of NLV I, New Leaf Venture Management I, L.L.C. ("NLV Management"), the sole general partner of NLV Venture Management, and the individual managers of NLV Management (NLV Venture Management, NLV Management and the individual managers of NLV Management each, an "Indirect Reporting Person"). The individual managers of NLV Management filing jointly with NLV I, NLV Venture Management and NLV Management are Philippe O. Chambon, James Niedel, Vijay Lathi, Jeani Delagardelle, Ronald Hunt and Srinivas Akkaraju. Each Indirect Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NLV I shares in which such Indirect Reporting Person has no actual pecuniary interest therein.
Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $4.50 to $4.43 per share. The reporting persons undertake to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.